| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |